ES2080954T3 - Uso de beta-aletina en cultivos de celulas y en terapia. - Google Patents

Uso de beta-aletina en cultivos de celulas y en terapia.

Info

Publication number
ES2080954T3
ES2080954T3 ES91912761T ES91912761T ES2080954T3 ES 2080954 T3 ES2080954 T3 ES 2080954T3 ES 91912761 T ES91912761 T ES 91912761T ES 91912761 T ES91912761 T ES 91912761T ES 2080954 T3 ES2080954 T3 ES 2080954T3
Authority
ES
Spain
Prior art keywords
beta
aletina
therapy
crops
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91912761T
Other languages
English (en)
Inventor
Galen Daryl Knight
Paul Leslie Mann
Terence Joseph Scallen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of New Mexico UNM
Original Assignee
University of New Mexico UNM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of New Mexico UNM filed Critical University of New Mexico UNM
Application granted granted Critical
Publication of ES2080954T3 publication Critical patent/ES2080954T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0093—Purging against cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LA (BETA)-ALETINA SE UTILIZA PARA LA DIFERENCIACION Y VITALIZACION DE CELULAS, TANTO EN APLICACIONES IN VIVO COMO IN VITRO. ENTRE LAS APLICACIONES PARTICULARES CABE INCLUIR EN USO DE LA (BETA)-ALETINA EN EL TRATAMIENTO DE TRASTORNOS Y ENFERMEDADES INMUNES, EN EL TRATAMIENTO DE LA NEOPLASIA Y EN LA PROMOCION DE CULTIVOS DE CELULAS.
ES91912761T 1990-07-06 1991-07-08 Uso de beta-aletina en cultivos de celulas y en terapia. Expired - Lifetime ES2080954T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54910390A 1990-07-06 1990-07-06
US54910490A 1990-07-06 1990-07-06

Publications (1)

Publication Number Publication Date
ES2080954T3 true ES2080954T3 (es) 1996-02-16

Family

ID=27069009

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91912761T Expired - Lifetime ES2080954T3 (es) 1990-07-06 1991-07-08 Uso de beta-aletina en cultivos de celulas y en terapia.

Country Status (9)

Country Link
EP (1) EP0538330B1 (es)
JP (1) JP3319597B2 (es)
AT (1) ATE128964T1 (es)
AU (1) AU646875B2 (es)
DE (1) DE69113802T2 (es)
DK (1) DK0538330T3 (es)
ES (1) ES2080954T3 (es)
GR (1) GR3018632T3 (es)
WO (1) WO1992000960A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643966A (en) * 1990-07-06 1997-07-01 University Of New Mexico β-alethine as anti-tumor agent
ATE186048T1 (de) * 1990-07-06 1999-11-15 Univ New Mexico Vitalethin und seine anwendung in zellkultur und therapie
US6245561B1 (en) 1990-07-06 2001-06-12 University Of New Mexico β-alethine use in cell culture and therapy
AU4372393A (en) * 1993-05-12 1994-12-12 Oculon Corporation Chemical prevention or reversal of cataract by phase separation inhibitors
AU718140B2 (en) 1995-10-17 2000-04-06 Dovetail Technologies, Inc. Low molecular weight cell, bone marrow and immune stimulants
US6762174B1 (en) 1998-02-24 2004-07-13 Dovetail Technologies, Inc. Low molecular weight compounds administered together with anti-cancer agents to prevent or treat cancer and pharmaceutical compositions thereof
WO1999042098A1 (en) * 1998-02-24 1999-08-26 Dovetail Technologies Inc. Small molecules that increase the conversion of food to body weight gain

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552765A (en) * 1982-05-14 1985-11-12 Santen Pharmaceutical Co., Ltd. Aletheine derivatives

Also Published As

Publication number Publication date
EP0538330A1 (en) 1993-04-28
EP0538330B1 (en) 1995-10-11
EP0538330A4 (en) 1993-07-07
GR3018632T3 (en) 1996-04-30
ATE128964T1 (de) 1995-10-15
AU8207791A (en) 1992-02-04
AU646875B2 (en) 1994-03-10
WO1992000960A1 (en) 1992-01-23
JPH05508769A (ja) 1993-12-09
DE69113802D1 (de) 1995-11-16
JP3319597B2 (ja) 2002-09-03
DK0538330T3 (da) 1996-02-26
DE69113802T2 (de) 1996-05-15

Similar Documents

Publication Publication Date Title
BR9910251A (pt) Estimulação hematopoiética
ES2170096T3 (es) Uso de lineas celulares fetales neuroderivadas para terapia de trasplantes.
ES2147720T3 (es) Factor de celulas madre.
DE68906161D1 (de) Ballon fuer medizinische einrichtung und dessen herstellung.
ES2192839T3 (es) Timosina beta 4 oxidada.
ES2080837T3 (es) Tratamiento de estados y enfermedades.
ES2112860T3 (es) Inmunoterapia adoptiva con interleukina-7.
TR200002218T2 (tr) 2-(Pürin-9-il)-Tetrahidrofüran -3,4-Diol türevleri
ES2170141T3 (es) 4-aminoderivados del acido micofenolico con actividad inmunosupresora.
CY1107778T1 (el) Ανθρωπινα cd45+ ή/και ινοβλαστης + μεσεγχυματικα βλαστικα κυτταρα
ES2152483T3 (es) Aplicacion terapeutica en anticuerpos quimericos y radiomarcados contra el antigeno de diferenciacion restringida de los linfocitos b humanos para el tratamiento del linfoma de celulas b.
ES2056854T3 (es) Tiadiazinonas.
BR0009964A (pt) Peptìdios artificiais com atividade desuperfìcie e sua utilização na preparação de surfactante artificial
IT1224594B (it) Impiego in terapeutica di derivati del 4h-benzo-4,5-cicloepta-1,2-bqti ofene
ES2093607T3 (es) Rna bicatenario para la correccion de anomalias en complejos inmunes circulantes y en la funcion de los monocitos.
ATE111735T1 (de) Verwendung des wirkstoffs azelastin und glycerinethern zur bekämpfung von psoriasis- erkrankungen.
ES2107414T3 (es) Utilizacion de interferon-beta humano para la estimulacion de la eritropoyesis.
ES2080954T3 (es) Uso de beta-aletina en cultivos de celulas y en terapia.
ATE311191T1 (de) Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen
ATE99669T1 (de) N-2,3-butadienyl-tri-aminoalkanderivate.
ES8700568A1 (es) Procedimiento para obtener complejos fviii-vwf para uso te- rapeutico
ES544664A0 (es) Procedimiento para el diagnostico in vitro del sexo
ITRM970238A0 (it) Uso del nerve growth factor nella conservazione di cornee in coltura, nella produzione di tessuti corneali e congiuntivali in vitro e nella terapia di patologie corneali e congiuntivali
ES2068714T3 (es) Derivados de pirimidina para aumentar la actividad antitumoral.
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 538330

Country of ref document: ES